Federal and State Gaps in Regulation of Hemp-Derived Delta-9-Tetrahydrocannabinol Beverages
- 4 November 2025
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 70 (2) , 108181
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism
This publication has 11 references indexed in Scilit:
- Non‐alcoholic beer labeling in the United StatesAddiction, 2025
- Potential Risks from Cannabis- Infused Beverages: A Critical ReviewCannabis, 2024
- The Food and Drug Administration’s Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023American Journal of Public Health, 2024
- Public health considerations about tetrahydrocannabinol‐infused beveragesAddiction, 2024
- Closing the Loophole on Hemp-Derived Cannabis ProductsJAMA, 2022
- The Hemp Loophole: A Need to Clarify the Legality of Delta-8-THC and Other Hemp-Derived Tetrahydrocannabinol CompoundsAmerican Journal of Public Health, 2021
- Cannabis Consumption, Purchasing and Sources among Young Canadians: The Cannabis Purchase and Consumption Tool (CPCT)Substance Use & Misuse, 2021
- Cannabis and the Developing Brain: Insights into Its Long-Lasting EffectsThe Journal of Neuroscience, 2019
- ‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administrationAddiction, 2019
- Co-use of Alcohol and Cannabis: A ReviewCurrent Addiction Reports, 2017